References
- W.N. Charman, C.J.H. Porter, S. Mithani, and J.B. Dressman, Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH, J. Pharm. Sci. 86 (1997), pp. 269–282.
- A. Avdeef, Absorption and Drug Development: Solubility, Permeability, and Charge State, 2nd ed., Wiley, Hoboken, NJ, 2012.
- Y. Tsume, P. Langguth, A. Garcia-Arieta, and G.L. Amidon, In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: Ibuprofen and ketoprofen, Biopharm. Drug Dispos. 33 (2012), pp. 366–377.
- D.T. Manallack, The acid–base profile of a contemporary set of drugs: Implications for drug discovery, SAR QSAR Environ. Res. 20 (2009), pp. 611–655.
- E.H. Kerns, L. Di, S. Petusky, M. Farris, R. Ley, and P. Jupp, Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery, J. Pharm. Sci. 93 (2004), pp. 1440–1453.
- Y. Sambuy, I.D. Angelis, G. Ranaldi, M.L. Scarino, A. Stammati, and F. Zucco, The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics, Cell Biol. Toxicol. 21 (2005), pp. 1–26.
- P. Artursson, Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells, J. Pharm. Sci. 79 (1990), pp. 476–482.
- M. Kansy, F. Senner, and K. Gubernator, Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes, J. Med. Chem. 41 (1998), pp. 1007–1010.
- B. Faller, Artificial membrane assay to assess permeability, Curr. Drug Metab. 9 (2008), pp. 886–892.
- C. Zhu, L. Jiang, T.-M. Chen, and K.-K. Hwang, A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential, Eur. J. Med. Chem. 37 (2002), pp. 399–407.
- M. Kansy, A. Avdeef, and H. Fischer, Advances in screening for membrane permeability: High-resolution PAMPA for medicinal chemists, Drug Discov. Today Technol. 1 (2004), pp. 349–355.
- K. Sugano, M. Kansy, P. Artursson, A. Avdeef, S. Bendels, L. Di, G.F. Ecker, B. Faller, H. Fischer, G. Gerebtzoff, H. Lennernäs, and F. Senner, Coexistence of passive and carrier-mediated processes in drug transport, Nature Rev. Drug Discov. 9 (2010), pp. 597–614.
- J. Ruell, Membrane-based drug assays. Permeability assays and oral absorption modeling can make the difference between drugs and dregs, Mod. Drug Discov. (2003), pp. 28–30.
- M. Kansy, F. Senner, and K. Gubernator, Physicochemical high throughput screening: Parallel artificial membrane permeability assay in the description of passive absorption processes, J. Med. Chem. 41 (1998), pp. 1007–1010.
- M. Fairstein, R. Swissa, and A. Dahan, Regional-dependent intestinal permeability and BCS classification: Elucidation of pH-related complexity in rats using pseudoephedrine, AAPS J. 15 (2013), pp. 589–597.
- K. Sugano, H. Hamada, M. Machida, H. Ushio, K. Saitoh, and K. Terada, Optimized conditions of bio-mimetic artificial membrane permeation assay, Int. J. Pharm. 228 (2001), pp. 181–188.
- M. Velicky, D.F. Bradley, K.Y. Tam, and R.A.W. Dryfe, In situ artificial membrane assay under hydrodynamic control: Permeability-pH profiles of warfarin and verapamil, Pharm. Res. 27 (2010), pp. 1644–1658.
- J.A. Ruell, K.L. Tsinman, and A. Avdeef, PAMPA—a drug absorption in vitro model: 5. Unstirred water layer in iso-pH mapping assays and pKaflux—optimized design (pOD-PAMPA), Eur. J. Pharm. Sci. 20 (2003), pp. 393–402.
- M. Oja and U. Maran, The permeability of an artificial membrane for wide range of pH in human gastrointestinal tract: Experimental measurements and quantitative structure-activity relationship, Mol. Inf. 34 (2015), pp. 493–506.
- R. Ano, Y. Kimura, M. Shima, R. Matsuno, T. Ueno, and M. Akamatsu, Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: Application to prediction of Caco-2 cell permeability, Bioorg. Med. Chem. 12 (2004), pp. 257–264.
- M. Fujikawa, R. Ano, K. Nakao, R. Shimizu, and M. Akamatsu, Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: Application to prediction of Caco-2 cell permeability, Bioorg. Med. Chem. 13 (2005), pp. 4721–4732.
- M. Fujikawa, K. Nakao, R. Shimizu, and M. Akamatsu, QSAR study on permeability of hydrophobic compounds with artificial membranes, Bioorg. Med. Chem. 15 (2007), pp. 3756–3767.
- C. Acharya, P.R. Seo, J.E. Polli, and A.D. MacKerell, Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranes, Mol. Pharm. 5 (2008), pp. 818–828.
- K. Nakao, M. Fujikawa, R. Shimizu, and M. Akamatsu, QSAR application for the prediction of compound permeability with in silico descriptors in practical use, J. Comput. Aided Mol. Des. 23 (2009), pp. 309–319.
- A. Avdeef and O. Tsinman, PAMPA – a drug absorption in vitro model 13. Chemical selectivity due to membrane hydrogen bonding: In combo comparison of HDM-, DOPC-, and DS-PAMPA models, Eur. J. Pharm. Sci. 28 (2006), pp. 43–50.
- Wiki-pKaTM database; available at http://www.in-adme.com/wiki_pka.php.
- R.J. Prankerd, Critical compilation of pKa values for pharmaceutical substances, in Profiles of Drug Substances, Excipients, and Related Methodology, H.G. Brittain (ed), Vol. 33, Elsevier, New York, 2007.
- S.H. Cheeseman, S.E. Hattox, M.M. McLaughlin, R.A. Koup, C. Andrews, C.A. Bova, J.W. Pav, T. Roy, J.L. Sullivan, and J.J. Keirns, Pharmacokinetics of nevirapine: Initial single-rising-dose study in humans, Antimicrob. Agents Chemother. 37 (1993), pp. 178–182.
- E. Jiménez-Lozano, I. Marqués, D. Barrón, J.L. Beltrán, and J. Barbosa, Determination of pKa values of quinolones from mobility and spectroscopic data obtained by capillary electrophoresis and a diode array detector, Anal. Chim. Acta. 464 (2002), pp. 37–45.
- M. Blas and B.R. McCord, Determination of trace levels of benzodiazepine in urine using capillary electrochromatography-time of flight mass spectrometry, Electrophoresis 29 (2008), pp. 2182–2192.
- M.E. Dasenaki and N.S. Thomaidis, Multianalyte method for the determination of pharmaceuticals in wastewater samples using solid-phase extraction and liquid chromatography-tandem mass spectrometry, Anal. Bioanal. Chem. 407 (2015), pp. 4229–4245.
- M. Shalaeva, J. Kenseth, F. Lombardo, and A. Bastin, Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers, J. Pharm. Sci. 97 (2008), pp. 2581–2606.
- M.A. Martinez-Gomez, R.M. Villanueve-Camanas, S. Sagrado, and M.J. Medina-Hernandez, Potential of human serum albumin as chiral selector of basic drugs in affinity electrokinetic chromatography-partial filling technique, Electrophoresis 27 (2006), pp. 4364–4374.
- C. Salerno, A.M. Carlucci, and C. Bregni, Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms, AAPS PharmSciTech. 11 (2010), pp. 986–993.
- M.M. Al Omari, M.I. El-Barghouthi, M.B. Zughul, J.E.D. Davies, and A.A. Badwan, Comparative study of the inclusion complexation of pizotifen and ketotifen with native and modified cyclodextrins, J. Solution Chem. 37 (2008), pp. 249–264.
- A. Checa, V.G. Soto, S. Hernandez-Cassou, and J. Saurine, Fast determination of pKa values of reverse transcriptase inhibitor drugs for AIDS treatment by using pH-gradient flow-injection analysis and multivariate curve resolution, Anal. Chim. Acta 554 (2005), pp. 177–183.
- MacroModel version 9, Schrödinger, , Portland, OR, USA, 2000; software available at http://www.schrodinger.com.
- J.J.P. Stewart, MOPAC Program Package 7.0, QCPE Bloomiagton, IN, USA, 1993.
- CODESSA PRO User’s manual, University of Florida, Gainsville, FL, USA, 2005.
- Syracuse Research Corporation, Physical/chemical Property Database–(PHYSPROP), SRC Environmental Science Centre, Syracuse, NY, USA, 1994.
- T. Cheng, Y. Zhao, X. Li, F. Lin, Y. Xu, X. Zhang, Y. Li, R. Wang, and L. Lai, Computation of octanol-water partition coefficients by guiding an additive model with knowledge, J. Chem. Inf. Model. 47 (2007), pp. 2140–2148.
- E. Bolton, Y. Wang, P.A. Thiessen, and S.H. Bryant, PubChem: Integrated Platform of Small Molecules and Biological Activities, in Annual Reports in Computational Chemistry, Volume 4, American Chemical Society, Washington DC, 2008, Chapter 12.
- PubChem database, available at http://pubchem.ncbi.nlm.nih.gov.
- JChem for Excel 14.7.2800.480, 2014, ChemAxon; available at http://www.chemaxon.com.
- A.C. Atkinson, Plots, Transformation, Regression: An Introduction to Graphical Methods of Diagnostic Regression Analysis, Oxford University Press, Oxford, UK, 1985.
- J. Jaworska, N. Nikolova-Jeliazkova, and T. Aldenberg, QSAR applicability domain estimation by projection of the training set in descriptor space: A review, ATLA 33 (2005), pp. 445–459.
- A. Tropsha, P. Gramatica, and V.K. Gombar, The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models, QSAR Comb. Sci. 22 (2003), pp. 69–77.
- T.I. Netzeva, A.P. Worth, T. Aldenberg, R. Benigni, M.T.D. Cronin, P. Gramatica, J.S. Jaworska, S. Kahn, G. Klopman, C.A. Marchant, G. Myatt, N. Nikolova-Jeliazkova, G.Y. Patlewicz, R. Perkins, D.W. Roberts, T.W. Schultz, D.T. Stanton, J.J.M. van de Sandt, W. Tong, G. Veith, and C. Yang, Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships, Altern. Lab. Anim. 33 (2005), pp. 155–173.
- V. Ruusmann, S. Sild, and U. Maran, QSAR DataBank – an approach for the digital organization and archiving of QSAR model information, J. Cheminf. 6 (2014), no. 25.
- V. Ruusmann, S. Sild, and U. Maran, QSAR DataBank repository: Open and linked qualitative and quantitative structure–activity relationship models, J. Cheminf. 7 (2015), no. 32.
- QsarDB repository; available at http://qsardb.org.
- C. Suenderhauf, F. Hammann, A. Maunz, C. Helma, and J. Huwyler, Combinatorial QSAR modeling of human intestinal absorption, Mol. Pharm. 8 (2010), pp. 213–224.
- T. Hou, J. Wang, W. Zhang, and X. Xu, ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification, J. Chem. Inf. Model. 47 (2007), pp. 208–218.